Italia markets closed
  • ESSA Pharma Presents Therapeutic Potential of EPI-7386 at 32nd EORTC-NCI-AACR Symposium
    PR Newswire

    ESSA Pharma Presents Therapeutic Potential of EPI-7386 at 32nd EORTC-NCI-AACR Symposium

    ESSA Pharma Inc. (Nasdaq: EPIX) (TSXV: EPI), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today presented new preclinical data on ESSA's clinical candidate, EPI-7386, at the 32nd EORTC-NCI-AACR Annual Symposium on Molecular Targets and Cancer Therapeutics ("ENA").

  • Lianluo Smart Limited and Newegg Inc. Announce Entering into Merger Agreement
    PR Newswire

    Lianluo Smart Limited and Newegg Inc. Announce Entering into Merger Agreement

    Lianluo Smart Limited ("LLIT" or the "Company") (NASDAQ: LLIT), and privately-held Newegg Inc. ("Newegg") today jointly announced that they have entered into an Agreement and Plan of Merger (the "Merger Agreement"), whereby the stockholders of Newegg will become the majority owners of LLIT, as a result of the merger of Lightning Delaware Sub, Inc. (the "Merger Sub"), LLIT's wholly owned subsidiary, with and into Newegg. In addition, LLIT will sell its equity holdings in Lianluo Connection Medical Wearable Device Technology (Beijing) Co., Ltd. ("Lianluo Connection") to Beijing Fenjin Times Technology Development Co., Ltd ("Fenjin Times") pursuant to an equity transfer agreement ("Disposition Agreement"). The disposition will become effective immediately following completion of the Merger.

  • Can You Imagine How Jubilant BlueScope Steel's (ASX:BSL) Shareholders Feel About Its 257% Share Price Gain?
    Simply Wall St.

    Can You Imagine How Jubilant BlueScope Steel's (ASX:BSL) Shareholders Feel About Its 257% Share Price Gain?

    The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...